Your browser doesn't support javascript.
loading
Recovery from Bell's palsy after treatment using uncultured umbilical cord-derived mesenchymal stem cells: A case report.
Ahn, Hyunjun; Jung, Won-Ju; Lee, Sang Yeon; Lee, Kye-Ho.
Afiliación
  • Ahn H; Stem Cell Treatment and Research Institute, bio Beauty and Health Company, Seoul 04420, South Korea.
  • Jung WJ; Stem Cell Treatment, 97.7 Beauty and Health Clinic, Seoul 04420, South Korea.
  • Lee SY; Stem Cell Treatment and Research Institute, bio Beauty and Health Company, Seoul 04420, South Korea.
  • Lee KH; Stem Cell Treatment and Research Institute, bio Beauty and Health Company, Seoul 04420, South Korea. khlee@stc365.com.
World J Clin Cases ; 11(12): 2817-2824, 2023 Apr 26.
Article en En | MEDLINE | ID: mdl-37214571
BACKGROUND: Bell's palsy is an idiopathic facial palsy with an unknown cause, and 75% of patients heal spontaneously. However, the other 25% of patients continue experiencing mild or severe disabilities, resulting in a reduced quality of life. Currently, various treatment methods have been developed to treat this disease. However, there is controversy regarding their effectiveness, and new alternative treatments are needed. CASE SUMMARY: The patient suffered from left-sided facial paralysis due to Bell's palsy for 7 years. The patient received an uncultured umbilical cord-derived mesenchymal stem cell transplant eight times for treatment. After follow-up for 32 mo, the paralysis was cured, and there was no recurrence. CONCLUSION: Uncultured umbilical cord-derived mesenchymal stem cell transplantation may be a potential treatment for patients with Bell's palsy who do not spontaneously recover.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Aspecto: Patient_preference Idioma: En Revista: World J Clin Cases Año: 2023 Tipo del documento: Article País de afiliación: Corea del Sur Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Aspecto: Patient_preference Idioma: En Revista: World J Clin Cases Año: 2023 Tipo del documento: Article País de afiliación: Corea del Sur Pais de publicación: Estados Unidos